Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HCFA Updated OPPS List Includes 456 Devices Eligible For Higher Payments

This article was originally published in The Gray Sheet

Executive Summary

The Health Care Financing Administration's most recent update to its list of devices eligible for reimbursement under the Medicare outpatient prospective payment system appears to address industry's concern that the system would establish an artificial market for certain devices.
Advertisement

Related Content

Medicare OPPS Administrative Burden On CMS Is Of Concern To MedPAC
Medicare OPPS Administrative Burden On CMS Is Of Concern To MedPAC
Medtronic IsoMed Implantable Drug Pump Approval Has Dual Indications
Mentor Alpha I Penile Prosthesis Included On OPPS "Pass-Through" Update
Medtronic IsoMed Implantable Drug Pump Approval Has Dual Indications
Mentor Alpha I Penile Prosthesis Included On OPPS "Pass-Through" Update
Industry Unsatisfied With HCFA Pledge To Expand OPPS Pass-Through List
Industry Meeting With HCFA Aimed At Amending "Final" OPPS List By July 1
Industry Meeting With HCFA Aimed At Amending "Final" OPPS List By July 1
Advertisement
UsernamePublicRestriction

Register

MT013665

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel